Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 32.70% vs -37.99% in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 18.18% vs 0.00% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is -1.20% vs -1.32% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 16.36% vs 5.95% in Mar 2024
Compare Balance Sheet Results of Shukra Pharma.
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
43.79
22.25
21.54
96.81%
Share Warrants & Outstandings
Total Reserve
19.05
302.29
-283.24
-93.70%
Shareholder's Funds
62.84
324.54
-261.70
-80.64%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
3.11
31.35
-28.24
-90.08%
Secured Loans
1.64
31.33
-29.69
-94.77%
Unsecured Loans
1.48
0.02
1.46
7,300.00%
Deferred Tax Assets / Liabilities
3.41
12.86
-9.45
-73.48%
Other Long Term Liabilities
0.13
0.00
0.13
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
2.81
-2.81
-100.00%
Total Non-Current Liabilities
6.65
47.02
-40.37
-85.86%
Current Liabilities
Trade Payables
9.22
51.54
-42.32
-82.11%
Other Current Liabilities
4.27
34.05
-29.78
-87.46%
Short Term Borrowings
1.06
23.95
-22.89
-95.57%
Short Term Provisions
2.74
0.00
2.74
0.00%
Total Current Liabilities
17.28
109.54
-92.26
-84.22%
Total Liabilities
86.77
481.09
-394.32
-81.96%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
43.42
427.18
-383.76
-89.84%
Less: Accumulated Depreciation
24.03
100.69
-76.66
-76.13%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
19.40
326.49
-307.09
-94.06%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
1.95
3.97
-2.02
-50.88%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.01
-0.01
-100.00%
Long Term Loans & Advances
0.00
10.10
-10.10
-100.00%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
21.34
340.56
-319.22
-93.73%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
9.95
70.04
-60.09
-85.79%
Sundry Debtors
8.77
50.08
-41.31
-82.49%
Cash and Bank
12.12
0.26
11.86
4,561.54%
Other Current Assets
20.17
0.82
19.35
2,359.76%
Short Term Loans and Advances
14.42
19.33
-4.91
-25.40%
Total Current Assets
65.43
140.53
-75.10
-53.44%
Net Current Assets (Including Current Investments)
48.14
31.00
17.14
55.29%
Total Current Assets Excluding Current Investments
65.43
140.53
-75.10
-53.44%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
86.77
481.09
-394.32
-81.96%
Contingent Liabilities
1.40
0.00
1.40
0.00%
Total Debt
4.18
55.30
-51.12
-92.44%
Book Value per share (adjusted)
1.44
145.86
-144.42
-99.01%
Annual - Borrowings
Borrowings 4.18 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 32.70% vs -37.99% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.13 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 18.18% vs 0.00% in Mar 2024
Annual - Fixed Assets
Fixed Assets 21.34 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -1.20% vs -1.32% in Mar 2024
Annual - Investments
Investments 0.00 Cr
in Mar 2025Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 65.43 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 16.36% vs 5.95% in Mar 2024






